Product image of Moxidox (Moxifloxacin) supplied by GNH India

Moxidox

Active Ingredient:
Moxifloxacin
Origin:
EU

Moxidox (Moxifloxacin)

Moxifloxacin, the active ingredient in Moxidox, is a fluoroquinolone antibiotic presented as an oral tablet for oral use. It treats a variety of bacterial infections in adult patients, including community‑acquired bacterial pneumonia, acute bacterial sinusitis, chronic bronchitis exacerbations, complicated skin‑structure infections and intra‑abdominal infections.

GNH India supplies Moxidox as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for global healthcare providers, with a focus on timely delivery and regulatory compliance.

Manufacturer / TM Owner

Maddox Pharma Swiss B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Moxidox (moxifloxacin) is a fluoroquinolone antibiotic used to treat bacterial infections in several organ systems.

  • Community‑acquired bacterial pneumonia: effective eradication of the causative pathogens.
  • Acute bacterial sinusitis: rapid resolution of sinus inflammation and infection.
  • Acute bacterial exacerbation of chronic bronchitis: reduces bacterial load and improves respiratory function.
  • Complicated skin and skin‑structure infections: clears infection in deep or extensive skin lesions.
  • Intra‑abdominal infections: treats polymicrobial infections within the abdominal cavity.

How It Works

  • Moxifloxacin inhibits bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication and transcription. By binding to these enzymes, it prevents the unwinding and resealing of DNA strands, halting bacterial cell division and leading to bacterial cell death. This broad‑spectrum activity covers many Gram‑positive and Gram‑negative organisms.

Side Effects

Moxidox may cause adverse reactions, which are categorized by frequency and severity.

Common Side Effects

  • Nausea
  • Diarrhea
  • Headache
  • Dizziness

Serious or Rare Side Effects

  • Tendon rupture or inflammation
  • QT interval prolongation leading to cardiac arrhythmias
  • Severe allergic reactions, including anaphylaxis and Stevens‑Johnson syndrome

Precautions & Warnings

When prescribing Moxidox, clinicians should consider the following precautions.

  • Renal impairment: assess renal function and adjust therapy if needed.
  • History of tendon disorders: avoid use in patients with prior tendon injury.
  • Cardiac arrhythmias: monitor QT interval, especially in patients with known risk factors.
  • Concomitant QT‑prolonging drugs: avoid or use with caution.
  • Elderly patients: increased risk of adverse events, monitor closely.
  • Store at below 25°C: keep in the original pack, protect from moisture.

Avoid Interactions

Moxidox can interact with other medicines; notable interactions are grouped by clinical significance.

Major Interactions (Avoid)

  • Antacids containing aluminum or magnesium: reduce moxifloxacin absorption.
  • Warfarin: may increase anticoagulant effect and bleeding risk.
  • Cyclosporine: can raise moxifloxacin plasma concentrations.

Moderate Interactions (Monitor Closely)

  • NSAIDs: potential for central nervous system stimulation.
  • Theophylline: may increase theophylline plasma levels, requiring dose adjustment.

Frequently Asked Questions

Moxidox contains moxifloxacin, a fluoroquinolone antibiotic indicated for adult patients with community‑acquired bacterial pneumonia, acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, complicated skin and skin‑structure infections, and intra‑abdominal infections.

Moxifloxacin blocks bacterial DNA gyrase and topoisomerase IV, enzymes required for DNA replication and transcription. Inhibiting these enzymes stops bacterial cells from multiplying, leading to bacterial death and resolution of the infection.

The prescribed dose of Moxidox is determined by the treating clinician based on the specific infection, patient characteristics, and local guidelines. Dosage regimens are not disclosed here and should follow the prescriber’s instructions.

Safety data for moxifloxacin in pregnancy and lactation are limited. The drug should only be used if the potential benefit justifies the potential risk to the fetus or infant, and this decision must be made by a qualified healthcare professional.

Enquiries can be submitted on the product page at gnhindia.com by providing the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then replies with pricing, availability, shipping details and any necessary import documentation.

Moxidox (moxifloxacin) offers a broader spectrum of activity against both Gram‑positive and Gram‑negative bacteria compared with some older fluoroquinolones, and it has enhanced penetration into respiratory tissues, making it a preferred option for certain pulmonary infections.

Moxidox tablets should be stored at temperatures below 25 °C, in the original packaging, and protected from moisture and direct sunlight to maintain stability and potency.

Moxidox is taken orally, usually as a tablet, with or without food as directed by the prescriber. The exact administration instructions, including timing and whether to take with water, should follow the healthcare professional’s guidance.

Serious risks include tendon rupture or inflammation, QT interval prolongation that can lead to cardiac arrhythmias, and severe hypersensitivity reactions such as anaphylaxis or Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they experience any of these symptoms.

Moxidox should be avoided in patients with a known hypersensitivity to moxifloxacin or other fluoroquinolones, those with a history of tendon disorders related to fluoroquinolone use, and individuals taking medications that significantly prolong the QT interval unless closely monitored.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Moxifloxacin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT